Results 151 to 160 of about 2,279,170 (397)

Analysis of protection blinding in active distribution grids

IET Renewable Power Generation
Protection blinding is a challenging issue in renewables‐penetrated distribution grids and refers to a situation where a circuit breaker may not trip due to fault current contribution from distributed generation.
Amit Dilip Patil, Abdorasoul Ghasemi, Hermann de Meer   +2 more
doaj   +1 more source

SPECIFIC ISSUES OF DISTRIBUTED GENERATION IN POWER SYSTEMS [PDF]

Journal of Sustainable Energy, 2016
Distributed Generation Systems (DGS) gets lately more and more importance in the context of concepts re-thinking within the electricity distribution networks.
BUNDA S.
doaj  

Overview of Control and Grid Synchronization for Distributed Power Generation Systems

IEEE transactions on industrial electronics (1982. Print), 2006
F. Blaabjerg, R. Teodorescu, Marco Liserre, A. Timbus   +3 more
semanticscholar   +1 more source

The MMP‐9/TIMP‐1 Ratio and Concentrations of Osteopontin Are Elevated in Cerebrospinal Fluid of People With Multiple Sclerosis and Decrease After Autologous Hematopoietic Stem Cell Transplantation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives To evaluate the utility of cerebrospinal fluid (CSF) biomarkers—matrix metalloproteinase‐9 (MMP‐9), tissue inhibitor of metalloproteinases‐1 (TIMP‐1), the MMP‐9/TIMP‐1 ratio, and osteopontin (OPN)—as indicators of blood–brain barrier (BBB) integrity and disease activity in people with relapsing–remitting multiple sclerosis (pwMS ...
Ivan Pavlovic, Ida Erngren, Kim Kultima, Anders Larsson, Malin Müller, Anna Wiberg, Joachim Burman   +6 more
wiley   +1 more source

Simultaneous and Incremental Approach for Optimal Placement and Sizing of Multiple Distributed Generations in Distribution System for Minimization of Power Losses

, 2020
Nisha R. Godha, V.N. Bapat, Iranna Korachagaon   +2 more
openalex   +1 more source

MOBSDEA-BASED OPTIMAL SIZING AND SITING OF RENEWABLE ENERGY-BASED DISTRIBUTED GENERATION UNITS TO REDUCE: POWER LOSSES, ELECTRICAL ENERGY COST AND VOLTAGE PROFILE DEVIATION

, 2023
Ali Darvish Falehi, Mosayeb Moradi, Maryam Najafi, Ali Kakavand   +3 more
openalex   +1 more source

Analysis of distribution systems in the presence of electric vehicles and optimal allocation of distributed generations considering power loss and voltage stability index [PDF]

, 2023
S. Sivakumar, Sarvesh Babu Ramasamy Gunaseelan, M. Krishnakumar, Narayanan Krishnan, Anurag Sharma, Alexander Águila Téllez   +5 more
openalex   +1 more source

The Relationship Between Inflammation and Central Nervous System in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Aim Multiple sclerosis is an autoimmune demyelination disease that is seen especially in the young population and has a progressive course, causing motor, sensory, and cognitive deficits. In the literature, the pathogenesis of MS disease and the interconnection between the immune and central nervous system in the disease have not been fully ...
Gamze Ansen, Ali Behram Salar, Abdulkadir Ermis, Erkingul Birday, Lutfu Hanoglu, Bayram Ufuk Sakul   +5 more
wiley   +1 more source

Nationwide Survey of Atopic Myelitis and Plexin D1‐Immunoglobulin G‐Related Pain

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To elucidate the features of plexin D1‐immunoglobulin (Ig)G‐associated neuropathic pain and its relationship to atopic myelitis (AM) in a nationwide Japanese survey. Methods A preliminary survey questionnaire was sent to 1574 selected departments (neurology and pediatrics/pediatric neurology) to explore the numbers of AM and plexin ...
Jun‐ichi Kira, Xu Zhang, Takayuki Fujii, Mikio Mitsuishi, Miho Ushijima, Sato Yoshidomi, Ayako Sakoda, Tomohiro Imamura, Satoshi Kuwabara, Noriko Isobe, Yuri Nakamura   +10 more
wiley   +1 more source

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source